GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention medication
GLP-1 (glucagon-like peptide-1 receptor agonists) medications, currently popular for weight loss, may help prevent type 2 diabetes and lower the risk of heart attack and stroke more than the standard diabetes prevention medication metformin among people with prediabetes, according to new, independent, preliminary research presented at the American Heart Association's Scientific Sessions 2026,…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials
United Kingdom
-
Hypertension or diabetes before pregnancy linked to higher risk of fetal heart defects
United Kingdom
-
Cardiac arrest ICU admissions rose with outdoor heat, especially in women, older adults
United Kingdom
-
Wearable devices + AI analysis may predict high blood pressure crisis up to 3 days early
United Kingdom
-
Cannabis use linked to an increased risk of cardiovascular disease, especially strokes
United Kingdom
-
Survey finds gaps in use of cardiovascular-kidney-metabolic syndrome tools
United Kingdom
-
Retired NFL players, notably linemen, have high risk of artery plaque, independent study shows
United Kingdom
-
Energy drinks, stimulant products linked to cardiac arrest, heart attack in young adults
United Kingdom